These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 30909726)

  • 1. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.
    Goldenberg JR; Wang X; Lewandowski ED
    J Mol Cell Cardiol; 2016 May; 94():1-9. PubMed ID: 26995156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.
    Ellis JM; Mentock SM; Depetrillo MA; Koves TR; Sen S; Watkins SM; Muoio DM; Cline GW; Taegtmeyer H; Shulman GI; Willis MS; Coleman RA
    Mol Cell Biol; 2011 Mar; 31(6):1252-62. PubMed ID: 21245374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.
    Ho KL; Zhang L; Wagg C; Al Batran R; Gopal K; Levasseur J; Leone T; Dyck JRB; Ussher JR; Muoio DM; Kelly DP; Lopaschuk GD
    Cardiovasc Res; 2019 Sep; 115(11):1606-1616. PubMed ID: 30778524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.
    Lahey R; Wang X; Carley AN; Lewandowski ED
    Circulation; 2014 Nov; 130(20):1790-9. PubMed ID: 25266948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart.
    Carley AN; Maurya SK; Fasano M; Wang Y; Selzman CH; Drakos SG; Lewandowski ED
    Circulation; 2021 May; 143(18):1797-1808. PubMed ID: 33601938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure.
    Cao F; Maguire ML; McAndrew DJ; Lake HA; Neubauer S; Zervou S; Schneider JE; Lygate CA
    Basic Res Cardiol; 2020 Jan; 115(2):12. PubMed ID: 31925563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FABP5 Deficiency Impairs Mitochondrial Function and Aggravates Pathological Cardiac Remodeling and Dysfunction.
    Gao S; Li G; Shao Y; Wei Z; Huang S; Qi F; Jiao Y; Li Y; Zhang C; Du J
    Cardiovasc Toxicol; 2021 Aug; 21(8):619-629. PubMed ID: 33929718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Transition From Decompensated to Pathological Hypertrophy.
    Pascual F; Schisler JC; Grevengoed TJ; Willis MS; Coleman RA
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.
    Paul DS; Grevengoed TJ; Pascual F; Ellis JM; Willis MS; Coleman RA
    Biochim Biophys Acta; 2014 Jun; 1841(6):880-7. PubMed ID: 24631848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction.
    Hinder LM; Figueroa-Romero C; Pacut C; Hong Y; Vivekanandan-Giri A; Pennathur S; Feldman EL
    Antioxid Redox Signal; 2014 Aug; 21(4):588-600. PubMed ID: 23991914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.
    Li J; Minćzuk K; Massey JC; Howell NL; Roy RJ; Paul S; Patrie JT; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
    J Am Heart Assoc; 2020 Apr; 9(7):e015154. PubMed ID: 32248762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
    Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
    Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
    Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
    Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
    Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
    Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
    Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.